Drugmakers Ripping Off Americans for Ozempic: Study Reveals Shocking Truth About Pricing Strategy
Copenhagen, Denmark – A recent study conducted by researchers from Yale University, King’s College Hospital in London, and Doctors Without Borders revealed staggering cost differences in the production and pricing of the diabetes and obesity treatment drug, Ozempic. The study found that despite being able to produce a month’s supply of Ozempic for as little as 89 cents to $4.73, Novo Nordisk A/S charges a monthly list price of $968.52 for the drug in the …